We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.50 | 1.40 | 1.60 | 1.50 | 1.50 | 1.50 | 195,426 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.29 | 2.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/4/2024 00:33 | Critical, the last time you posted, the price was higher than this, so what do you mean nice and steady? | davevt | |
23/4/2024 10:34 | Spot on CT1 | ant15 | |
23/4/2024 10:02 | Nice and steady 👌 | criticalthinker1 | |
19/3/2024 20:06 | Just because people may get excited and buy shares and The price goes up doesn't mean revenues are linked to mcap, because this share is currently sitting lower, with a lower mcap than previously, AFTER releasing news of new contracts and revenues. So that just blew your theory didn't it.. | davevt | |
19/3/2024 13:15 | It's not just good news, it's great news. Existing big pharma client putting more business the company's way. More of that please! Market makers persisting with the daft spread, buys actually above 1.3p. | le mass du pap | |
19/3/2024 12:54 | It's new business, new money, new income and a significant proportion of the company's entire market capitalisation, so of course it's significant. No doubt if they'd lost the client you'd be saying it's significant. A quick look at your posts shows you've been negative on everything PYC related for some time, and only PYC. So you've clearly got something against this company in particular and therefore your comments cannot be taken seriously. There's one on every board. | simonsmithiv | |
19/3/2024 12:33 | Comparison to mcap is irrelevant. They aren't even related metrics. And it's an existing customer. You're meant to keep existing customers. You have a very low bar if a repeat customer using the services you're meant to do is 'good news'. | davevt | |
18/3/2024 16:12 | Because it's a new contract and it's £178k (not 150k). And because it's >10% of the mcap over just 6 months, >20% yearly. So it is significant, even though it's 'what they're meant to do'. It's very good news, with plenty more to come by the sounds of it. | simonsmithiv | |
18/3/2024 15:57 | Because it's only 150k for 6 months work. I don't even know why pyc release and rns for doing what they are meant to do. | davevt | |
18/3/2024 14:23 | Good news this am with a decent sized contract for such a small market cap, surprised it hasn't kicked on yet. The investor presentation sounded solid, with a focus on expanding income streams, securing new clients and contracts and very much pushing on from here. CEO sounded positive and hinted at more news to come with the pipeline for this year up significantly. Therefore I can only assume we have seen the lows? | le mass du pap | |
18/3/2024 10:20 | Rising on contract award from oversold RSI and tight sma's at the thin end of the squeeze. Investor presentation later today. free stock charts from uk.advfn.com | simonsmithiv | |
18/3/2024 09:00 | Mcap only £1.6m | simonsmithiv | |
18/3/2024 08:24 | And another one. Quite interesting this one! | criticalthinker1 | |
18/3/2024 08:14 | That's better, over 10% of the mcap in one contract award. | simonsmithiv | |
07/3/2024 07:59 | There's start ups on Dragons Den making more than this. | simonsmithiv | |
07/3/2024 07:28 | “The Directors believe the Company will continue to trade in line with market expectations.“ So after all that waffle and more than 2 decades of constant loss making, they are expecting more of the same. Exciting times huh. | terminator101 | |
21/2/2024 18:09 | This was a steal last August and the fundamentals have only improved. Happy to be invested here. | criticalthinker1 | |
20/2/2024 16:29 | I'm glad he is still alive share14 - where's he at? | ydderf | |
20/2/2024 11:46 | You should pop in on dencs and say hi Freddy | share14 | |
19/2/2024 10:46 | the RNS cost £0.4k and that's assuming it was written entirely in-house | ydderf | |
19/2/2024 07:40 | £45k PMSL | terminator101 | |
19/2/2024 07:09 | Nice and steady. Great communication. Sareum could learn a few things from Physiomics about treating the shareholders with respect and promises made at 8nvestor meets. | criticalthinker1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions